Targeting of drugs and nanoparticles to tumors
Name
Ruoslahti-2010-Targeting of drugs a.pdf
Size
2.21 MB
Format
Adobe PDF
Checksum (MD5)
63db9768b8363c692034a954c720bc6e
Author(s)
Rusolahti, Erkki
Bhatia, Sangeeta N.
Date Issued
March 2010
Journal
Journal of Cell Biology
Publisher
Rockefeller University Press
Citation
Ruoslahti, Erkki, Sangeeta N. Bhatia, and Michael J. Sailor. “Targeting of drugs and nanoparticles to tumors.” The Journal of Cell Biology 188.6 (2010): 759 -768.
Version
Final published version
Abstract
The various types of cells that comprise the tumor mass all carry molecular markers that are not expressed or are expressed at much lower levels in normal cells. These differentially expressed molecules can be used as docking sites to concentrate drug conjugates and nanoparticles at tumors. Specific markers in tumor vessels are particularly well suited for targeting because molecules at the surface of blood vessels are readily accessible to circulating compounds. The increased concentration of a drug in the site of disease made possible by targeted delivery can be used to increase efficacy, reduce side effects, or achieve some of both. We review the recent advances in this delivery approach with a focus on the use of molecular markers of tumor vasculature as the primary target and nanoparticles as the delivery vehicle.
MIT Department
Harvard University--MIT Division of Health Sciences and Technology
Massachusetts Institute of Technology. Department of Electrical Engineering and Computer Science
Terms of Use
Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1083/jcb.200910104
